Anonymous Survey of Breast Cancer Patients Concerning Their Use of Medical Apps

NCT ID: NCT05605184

Last Updated: 2024-11-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Breast cancer patients complete questionnaires concerning their use of medical apps.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Breast cancer patients of the department of gynecology at Technical University of Munich and Berlin Charité complete quesionnaires during routine appointments. Intention of the survey is to evaluate the importance of medical apps and the special needs of breast cancer patients. Moreover approaches to improve health care of breast cancer patients are expected to be developed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Care Survey

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Survey

Breast cancer patients complete questionnaire concerning their use of medical apps.

Survey

Intervention Type OTHER

Survey

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survey

Survey

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* breast cancer patients
* patients who are legally competent and able to understand and follow instructions of the study staff

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Technical University of Munich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Heike Jansen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Heike Jansen, Dr. med.

Role: PRINCIPAL_INVESTIGATOR

Technical University of Munich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum rechts der Isar, Frauenklinik, Technische Universität München

Munich, Germany, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Survey_App

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tumour Registry Breast Cancer
NCT01351584 COMPLETED
Early Detection of Breast Cancer Among Syrian Women
NCT07056686 ENROLLING_BY_INVITATION